Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tucows (TCX) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Tucows (TCX) over the last 11 years, with Q3 2025 value amounting to $10.9 million.

  • Tucows' Asset Writedowns and Impairment rose 117934.27% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.0 million, marking a year-over-year increase of 276393.13%. This contributed to the annual value of $19.2 million for FY2024, which is 29749.07% up from last year.
  • Latest data reveals that Tucows reported Asset Writedowns and Impairment of $10.9 million as of Q3 2025, which was up 117934.27% from $18.3 million recorded in Q4 2024.
  • Over the past 5 years, Tucows' Asset Writedowns and Impairment peaked at $18.3 million during Q4 2024, and registered a low of -$101000.0 during Q4 2021.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $74000.0 (2023), whereas its average is $2.3 million.
  • As far as peak fluctuations go, Tucows' Asset Writedowns and Impairment crashed by 9993.44% in 2021, and later skyrocketed by 8866666.67% in 2023.
  • Tucows' Asset Writedowns and Impairment (Quarter) stood at -$101000.0 in 2021, then skyrocketed by 161.39% to $62000.0 in 2022, then skyrocketed by 130.65% to $143000.0 in 2023, then surged by 12670.63% to $18.3 million in 2024, then tumbled by 40.31% to $10.9 million in 2025.
  • Its last three reported values are $10.9 million in Q3 2025, $18.3 million for Q4 2024, and $852000.0 during Q3 2024.